Eledon Pharmaceuticals, Inc. (ELDN) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,861
Total Return
-61.39%
CAGR
-17.33%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.06% |
| Median | -1.13% |
| Best | +108.01% |
| Worst | -65.69% |
| % of Windows Positive | 47.8% |
1-Year (252 Trading Days)
| Average | +6.46% |
| Median | -23.95% |
| Best | +318.73% |
| Worst | -69.75% |
| % of Windows Positive | 37.9% |
3-Year (756 Trading Days)
| Average | -10.14% |
| Median | -10.28% |
| Best | +84.73% |
| Worst | -70.09% |
| % of Windows Positive | 37.9% |
Risk Metrics
| Maximum Drawdown | -87.69% |
| Average Drawdown | -65.45% |
| Drawdown Duration | 1253 Trading Days (Unrecovered) |
| Sortino Ratio | 0.23 |
| Calmar Ratio | -0.20 |
| CVaR (5%) | -10.12% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +131.38% (+631.27% ann.) | +$13137.76 | $0.00 | $0.00 | $0.00 |
| 2025 | -63.36% | $6336.45 | $0.00 | $0.00 | $0.00 |
| 2024 | +128.63% | +$12863.25 | $0.00 | $0.00 | $0.00 |
| 2023 | -20.95% | $2094.59 | $0.00 | $0.00 | $0.00 |
| 2022 | -48.34% | $4834.21 | $0.00 | $0.00 | $0.00 |
| 2021 | -71.36% | $7135.72 | $0.00 | $0.00 | $0.00 |
| 2020 | +47.53% | +$4752.95 | $0.00 | $0.00 | $0.00 |
| 2019 | -63.75% | $6375.30 | $0.00 | $0.00 | $0.00 |
| 2018 | -60.59% | $6059.20 | $0.00 | $0.00 | $0.00 |
| 2017 | -53.87% | $5387.49 | $0.00 | $0.00 | $0.00 |
| 2016 | -88.78% | $8878.43 | $0.00 | $0.00 | $0.00 |
| 2015 | -40.84% | $4084.13 | $0.00 | $0.00 | $0.00 |
| 2014 partial | -37.96% (-81.00% ann.) | $3796.30 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 17, 2014 – February 19, 2020 | -99.75% | -66.93% | $9975.26 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -38.68% | -99.62% | $3868.00 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +236.89% | +605.89% | +$23688.58 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -74.40% | -72.55% | $7440.00 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -51.89% | -54.02% | $5188.98 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +4.13% | +2.21% | +$413.35 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 19, 2024 – June 3, 2026 | +40.84% | +22.27% | +$4083.85 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.